-

HJF Announces Changes to Its Council of Directors

Wilensky Appointed Chair and Blanck Joins HJF’s Council of Directors

BETHESDA, Md.--(BUSINESS WIRE)--The Honorable Gail R. Wilensky, Ph.D., has been appointed Chair of The Henry M. Jackson Foundation for the Advancement of Military Medicine’s (HJF) Council of Directors (CoD). Dr. Wilensky, an economist and senior fellow at Project Hope, has been with HJF’s CoD since January 2020. She has more than 30 years of health sciences experience, including serving in the White House as a senior adviser on health and welfare issues to President GHW Bush. Her expertise covers strategies to reform health care, Medicare, comparative effectiveness research, and military healthcare.

“I look forward to working with Dr. Wilensky as the Chair of HJF’s Council of Directors,” said HJF President and CEO, Dr. Joseph Caravalho, Jr. “I have already witnessed her tremendous knowledge and commitment to HJF’s mission, and deeply value her advice and ideas about how to best advance military medicine efforts and results around the world.”

Additionally, Ronald R. Blanck, D.O., (Lieutenant General, U.S. Army, retired) will join the CoD as a Director. He is a partner and Chairman of the Board of Martin, Blanck & Associates. Dr. Blanck was the 39th Surgeon General of the United States Army and Commander of the U.S. Army Medical Command from 1996 to 2000. He was also the President of the University of North Texas Health Science Center at Fort Worth and for 12 years served as Chair of the Board of Regents for the Uniformed Services University of the Health Sciences.

The appointment of Dr. Wilensky follows the retirement of the former Chair, the Honorable John H. Dressendorfer, who becomes a Director Emeritus on HJF’s CoD.

See the entire HJF Council of Directors membership at https://www.hjf.org/council-directors.

About HJF
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) is a global nonprofit that administers more than $500 million in medical research funds annually. HJF partners with researchers and clinicians to provide bench to bedside to battlefield research support. More than 3,000 HJF teammates ensure HJF is a trusted and responsive partner by providing scientific, administrative, and program operations services to researchers in the military, academia, and private industry. For more information, visit hjf.org.

Contacts

Colleen Franklin
Director of Communications
cfranklin@hjf.org

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Details
Headquarters: Bethesda, Maryland
Website: www.hjf.org
CEO: Joseph Caravalho
Employees: 3000
Organization: NON

Release Summary
Wilensky Appointed Chair and Blanck Joins HJF’s Council of Directors
Release Versions

Contacts

Colleen Franklin
Director of Communications
cfranklin@hjf.org

More News From The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

HJF Supporting Research of Treatment of Volumetric Muscle Loss

BETHESDA, Md.--(BUSINESS WIRE)--Volumetric Muscle Loss is frequently found in Service members with traumatic limb injuries. This may treat it....

CAMRIS Participates in Army’s Vaccine Research

BETHESDA, Md.--(BUSINESS WIRE)--CAMRIS International, LLC, an HJF Company, today announced its involvement in COVID-19 vaccine research by the Walter Reed Army Institute of Research (WRAIR). As recently reported in a leading scientific journal, the Army’s development of a COVID-19 vaccine using a Spike Ferritin Nanoparticle (SpFN) platform showed encouraging preclinical results. Also, as reported in The Hill, the developed vaccine may also have broader effectiveness against SARS-origin viruses...

HJF Hosts the Inaugural HJF Leadership Roundtable

BETHESDA, Md.--(BUSINESS WIRE)--HJF hosted its first Leadership Roundtable, bringing together leaders from the civilian and military medical research communities....
Back to Newsroom